Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 15/20 | 0.66 |
| ▸ | HSP90AB1 | P08238 | 15/20 | 0.66 |
| ▸ | HSP90B1 | P14625 | 4/20 | 0.56 |
| ▸ | TRAP1 | Q12931 | 4/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1220533 | 0.94 | HSP90AB1 (0.71) | HSP90AA1HSP90AB1HSP90B1TRAP1OPRM1 | |
| SCHEMBL14918499 | 0.89 | HSP90AB1 (0.64) | HSP90AA1HSP90AB1HSP90B1TRAP1OPRM1 | |
| SCHEMBL16883488 | 0.85 | HSP90AB1 (0.73) | HSP90AA1HSP90AB1HSP90B1TRAP1OPRM1 | |
| SCHEMBL14932861 | 0.85 | HSP90AB1 (0.59) | HSP90AA1HSP90AB1HSP90B1TRAP1OPRM1 | |
| SCHEMBL1219235 | 0.85 | HSP90AB1 (0.61) | HSP90AA1HSP90AB1HSP90B1TRAP1OPRM1 | |
| SCHEMBL16161829 | 0.84 | HSP90AB1 (0.77) | HSP90AA1HSP90AB1HSP90B1TRAP1OPRM1 | |
| SCHEMBL1220688 | 0.84 | HSP90AB1 (0.77) | HSP90AA1HSP90AB1HSP90B1TRAP1 | |
| SCHEMBL1220613 | 0.84 | HSP90AA1 (0.68) | HSP90AA1HSP90AB1HSP90B1TRAP1OPRM1 | |
| SCHEMBL1219504 | 0.84 | HSP90AA1 (0.68) | HSP90AA1HSP90AB1HSP90B1TRAP1OPRM1 | |
| SCHEMBL1220784 | 0.84 | HSP90AA1 (0.68) | HSP90AA1HSP90AB1HSP90B1TRAP1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013066831-A1 | COMPOUNDS AND METHODS | GLAXOSMITHKLINE LLC (US) | 2013-05-10 | — | — | WO | disclosed |
| WO-2013066831-A1 | COMPOUNDS AND METHODS | GLAXOSMITHKLINE LLC (US) | 2013-05-10 | — | — | WO | disclosed |